Metraipolis › archive › dc_b41654f6eaeb

Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression — Europe PMC PMID:41366520

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41366520
DOI
10.1038/s44321-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-07T18:50:06.557Z
SHA-256 of the archived text
a4cdb7a8e855ffadeb8a75a4143f77761eb3fdbfda6d051d1879cd72c8d5822f
Stable URL of this page
https://metraipolis.com/documento/dc_b41654f6eaeb

How to cite

Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression — Europe PMC PMID:41366520 — Europe PMC (en), https://europepmc.org/article/MED/41366520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b41654f6eaeb (Metraipolis archive dc_b41654f6eaeb, sha256 a4cdb7a8e855ffadeb8a75a4143f77761eb3fdbfda6d051d1879cd72c8d5822f)
BibTeX
@misc{dcb41654f6eaeb,
  title = {Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression — Europe PMC PMID:41366520},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41366520},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b41654f6eaeb; sha256 a4cdb7a8e855ffadeb8a75a4143f77761eb3fdbfda6d051d1879cd72c8d5822f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41366520. Agents can read the archived copy with the MCP tool read_document.